Correlation Engine 2.0
Clear Search sequence regions

  • adult (1)
  • bevacizumab (7)
  • cases (3)
  • edema (7)
  • follow up studies (1)
  • glucocorticoid (1)
  • hemiparesis (1)
  • humans (1)
  • patient (6)
  • seizures (1)
  • srs (2)
  • steroid (2)
  • Sizes of these terms reflect their relevance to your search.

    We present a 41-year old male patient who was admitted to our clinic with epileptic seizures, headaches and hemiparesis 14 months after SRS treatment for a left fronto-parietal Spetzler-Martin Grade III arteriovenous malformation (AVM). On his first-year follow-up perilesional edema was observed for which the patient received steroid treatment, but the patient did not show any benefit from it. In the cases of steroid resistant perilesional edemas, bevacizumab can be used for reducing symptoms and even radiological perilesional edema as well. In our case, we have seen the effect of bevacizumab for symptomatic perilesional edema in a AVM patient after SRS treatment after radiological / neurological recovery. Our patient's headaches decreased rapidly after 2 days after treatment and was able to mobilize himself after 2 months but total resolution of symptoms and radiological findings observed after 1,5 years. The duration and optimum dose of bevacizumab therapy needed to further investigation. Our study showed that bevacizumab was a long-term and effective treatment option for the cases with peritumoral edema resistant to glucocorticoid treatment, where the patient had conditions such as severe headache and neurological deficits.


    Ece Uysal, Ozan Başkurt, İdris Avcı, Halil Olgun Peker, Suat Erol Çelik. Late recovery of stereotactic radiosurgery induced perilesional edema of an arteriovenous malformation after bevacizumab treatment. British journal of neurosurgery. 2021 Feb;35(1):22-26

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32216590

    View Full Text